Delivery Order SPE2DB20D3303-SPE2DB25FA1NU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,361.69 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price delivery order, awarded on July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $8,508.28 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor's corporate office is located in Conshohocken,...
- The Defense Logistics Agency awarded a $2,317.23 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with a contract value of $2,265.72 and an ultimate completion date of August 6, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery to support federal healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,111.65 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order valued at $4,526.78 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 31, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $2,479.02 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 15, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order executed on August 14, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $8,028.28. This competitively awarded, non-set-aside order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order carries a firm fixed price structure with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at approximately $4.95K to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units. The contract employs firm fixed pricing and carries a completion date of July 31, 2025. This non-set-aside competitive award reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor within the federal medical supply chain. The place of performance is located in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.05 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1NUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,726.70 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems, fulfilling this order from its corporate office location. AmerisourceBergen's comprehensive IDC with the Defense Logistics Agency functions as a global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's substantial contract portfolio with DLA demonstrates its capability to meet federal procurement requirements across multiple therapeutic domains, from brand-name and generic medications to specialized medical commodities. This specific delivery order for topical pain management medication reflects the company's ongoing role as a primary pharmaceutical distributor within the federal medical supply chain for defense operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/21/25 |